Synopsis

Source of validity: Scientific
Rating (out of 5): 1

Vitamin E (alpha-tocopheryl acetate) has been studied for its potential role in the prevention and treatment of cataracts, primarily due to its antioxidant properties. The rationale is that oxidative stress contributes to the development of cataracts, and antioxidants like vitamin E might mitigate this effect by neutralizing free radicals in the lens of the eye.

However, scientific evidence supporting vitamin E’s efficacy in cataract prevention or treatment is weak. Several observational studies have suggested an association between higher dietary or blood levels of vitamin E and a reduced risk of cataract formation, but these findings are inconsistent and do not establish causation. Randomized controlled trials (RCTs) provide more definitive evidence, and most large RCTs—including the Age-Related Eye Disease Study (AREDS) and its follow-up studies—have found no significant benefit of vitamin E supplementation, alone or in combination with other antioxidants, in preventing or slowing the progression of cataracts.

Major reviews and guidelines do not recommend vitamin E supplementation specifically for cataract prevention or treatment. While vitamin E continues to be included in some multivitamin formulations for eye health, its use for cataracts is not strongly supported by current scientific evidence.

In summary, while vitamin E has been considered for cataract support due to biological plausibility, the available scientific data does not justify its use as an effective intervention for this condition.

More about Vitamin E (alpha-tocopheryl acetate)
More about Cataracts

Other ingredients used for Cataracts

Other health conditions supported by Vitamin E (alpha-tocopheryl acetate)

Products containing Vitamin E (alpha-tocopheryl acetate)